Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cosmos Health (COSM) Common Equity (2016 - 2025)

Cosmos Health's Common Equity history spans 13 years, with the latest figure at $18.4 million for Q4 2025.

  • Quarterly results put Common Equity at $18.4 million for Q4 2025, down 24.9% from a year ago — trailing twelve months through Dec 2025 was $18.4 million (down 24.9% YoY), and the annual figure for FY2025 was $18.4 million, down 24.9%.
  • Common Equity for Q4 2025 was $18.4 million at Cosmos Health, down from $23.1 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $44.2 million in Q3 2023 to a low of -$2.8 million in Q1 2021.
  • The 5-year median for Common Equity is $25.2 million (2024), against an average of $22.4 million.
  • The sharpest move saw Common Equity surged 1234.05% in 2022, then plummeted 33.86% in 2025.
  • Year by year, Common Equity stood at $4.4 million in 2021, then surged by 797.01% to $39.3 million in 2022, then fell by 8.25% to $36.0 million in 2023, then tumbled by 31.93% to $24.5 million in 2024, then fell by 24.9% to $18.4 million in 2025.
  • According to Business Quant data, Common Equity over the past three periods came in at $18.4 million, $23.1 million, and $26.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.